These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38383215)

  • 1. Transforming drug development with synthetic biology and AI.
    Hill A; True JM; Jones CH
    Trends Biotechnol; 2024 Sep; 42(9):1072-1075. PubMed ID: 38383215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
    Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics.
    Arora P; Behera M; Saraf SA; Shukla R
    Curr Pharm Des; 2024; 30(28):2187-2205. PubMed ID: 38874046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of artificial intelligence and systems biology for intelligent vaccine design.
    Russo G; Reche P; Pennisi M; Pappalardo F
    Expert Opin Drug Discov; 2020 Nov; 15(11):1267-1281. PubMed ID: 32662677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities.
    David F; Davis AM; Gossing M; Hayes MA; Romero E; Scott LH; Wigglesworth MJ
    SLAS Discov; 2021 Jun; 26(5):581-603. PubMed ID: 33834873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
    Tayara H; Abdelbaky I; To Chong K
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic biology advances towards a bio-based society in the era of artificial intelligence.
    Iram A; Dong Y; Ignea C
    Curr Opin Biotechnol; 2024 Jun; 87():103143. PubMed ID: 38781699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.
    Das G; Das T; Chowdhury N; Chatterjee D; Bagchi A; Ghosh Z
    Genomics; 2021 Jan; 113(1 Pt 2):1129-1140. PubMed ID: 33189776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.
    Floresta G; Zagni C; Gentile D; Patamia V; Rescifina A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AI-based language models powering drug discovery and development.
    Liu Z; Roberts RA; Lal-Nag M; Chen X; Huang R; Tong W
    Drug Discov Today; 2021 Nov; 26(11):2593-2607. PubMed ID: 34216835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review.
    Singh K; Kaur N; Prabhu A
    Curr Top Med Chem; 2024; 24(8):737-753. PubMed ID: 38318824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review.
    Naseem M; Akhund R; Arshad H; Ibrahim MT
    J Prim Care Community Health; 2020; 11():2150132720963634. PubMed ID: 32996368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery.
    Abubaker Bagabir S; Ibrahim NK; Abubaker Bagabir H; Hashem Ateeq R
    J Infect Public Health; 2022 Feb; 15(2):289-296. PubMed ID: 35078755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indian contribution toward biomedical research and development in COVID-19: A systematic review.
    Kaur H; Kaur M; Bhattacharyya A; Prajapat M; Thota P; Sarma P; Kumar S; Kaur G; Sharma S; Prakash A; Saifuddin PK; Medhi B
    Indian J Pharmacol; 2021; 53(1):63-72. PubMed ID: 33976001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence (AI) applications for COVID-19 pandemic.
    Vaishya R; Javaid M; Khan IH; Haleem A
    Diabetes Metab Syndr; 2020; 14(4):337-339. PubMed ID: 32305024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19.
    Bannerman BP; Júlvez J; Oarga A; Blundell TL; Moreno P; Floto RA
    Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34353886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.
    Zambrana C; Xenos A; Böttcher R; Malod-Dognin N; Pržulj N
    Sci Rep; 2021 Sep; 11(1):18985. PubMed ID: 34556735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence and machine learning to fight COVID-19.
    Alimadadi A; Aryal S; Manandhar I; Munroe PB; Joe B; Cheng X
    Physiol Genomics; 2020 Apr; 52(4):200-202. PubMed ID: 32216577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.